OTC Markets OTCPK - Delayed Quote USD

C21 Investments Inc. (CXXIF)

0.3230 -0.0135 (-4.01%)
At close: May 28 at 3:52 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
1/31/2023
1/31/2022
1/31/2021
1/31/2020
Total Revenue
28,769.4400
28,888.4100
32,982.9760
33,466.0630
37,705.0950
Cost of Revenue
18,816.1780
15,487.2640
14,172.9910
15,418.7170
24,567.0490
Gross Profit
9,953.2620
13,401.1460
18,809.9850
18,047.3460
13,138.0460
Operating Expense
9,606.9780
9,445.9080
9,055.1740
8,807.3990
14,354.0370
Operating Income
346.2840
3,955.2380
9,754.8110
9,239.9470
-1,215.9910
Net Non Operating Interest Income Expense
-95.7400
-456.6910
-1,307.5300
-5,152.4660
-4,300.7510
Other Income Expense
-366.7340
692.7610
8,684.7600
-5,720.9200
-23,324.2250
Pretax Income
-116.1900
4,191.3080
17,132.0410
-1,633.4390
-28,840.9670
Tax Provision
2,430.3640
2,809.7680
4,934.4670
2,968.1330
3,714.6660
Net Income Common Stockholders
-3,382.4400
293.2110
9,954.9300
-7,829.6280
-32,555.6330
Diluted NI Available to Com Stockholders
-3,382.4400
293.2110
9,954.9300
-7,829.6280
-32,555.6330
Basic EPS
-0.03
0.00
0.08
-0.07
-0.43
Diluted EPS
-0.03
0.00
0.08
-0.07
-0.43
Basic Average Shares
120,047.8140
120,047.8140
118,308.5840
104,841.5400
76,683.8950
Diluted Average Shares
122,880.9070
122,880.9070
121,141.6770
104,841.5400
76,683.8950
Total Operating Income as Reported
346.2840
3,955.2380
9,754.8110
9,239.9470
-1,181.1070
Rent Expense Supplemental
591.3750
591.3750
591.3760
549.0310
--
Total Expenses
28,423.1560
24,933.1720
23,228.1650
24,226.1160
38,921.0860
Interest Income
--
--
--
--
2.3530
Interest Expense
95.7400
456.6910
1,307.5300
5,152.4660
4,300.7510
Net Interest Income
-95.7400
-456.6910
-1,307.5300
-5,152.4660
-4,300.7510
Net Income from Continuing & Discontinued Operation
-3,382.4400
293.2110
9,954.9300
-7,829.6280
-32,555.6330
Normalized Income
-2,352.6838
948.4858
6,091.4754
-370.7687
-15,232.8568
EBIT
-20.4500
4,647.9990
18,439.5710
3,519.0270
-24,540.2160
EBITDA
2,246.2590
6,981.7160
20,719.2600
5,789.5530
-19,558.6410
Reconciled Cost of Revenue
17,939.5410
14,518.5650
13,173.7480
14,469.8770
22,990.5900
Reconciled Depreciation
2,266.7090
2,333.7170
2,279.6890
2,270.5260
4,981.5750
Net Income from Continuing Operation Net Minority Interest
-2,546.5540
1,381.5400
12,197.5740
-4,601.5720
-32,555.6330
Total Unusual Items Excluding Goodwill
-323.1170
721.7570
8,576.2900
-5,756.1950
-23,568.4030
Total Unusual Items
-323.1170
721.7570
8,576.2900
-5,756.1950
-23,568.4030
Normalized EBITDA
2,569.3760
6,259.9590
12,142.9700
11,545.7480
4,009.7620
Tax Rate for Calcs
0.0004
0.0004
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-129.2468
288.7028
2,470.1914
-1,525.3917
-6,245.6268
1/31/2020 - 6/22/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VEXT.CN Vext Science, Inc.
0.2450
+4.26%
 
FFNTF 4Front Ventures Corp.
0.0900
-3.49%
 
LOWLF Lowell Farms Inc.
0.0766
-19.35%
 
AYURF Ayurcann Holdings Corp.
0.0326
-2.54%
 
CNTMF Cansortium Inc.
0.1625
-2.11%
 
SHWZ Medicine Man Technologies, Inc.
0.4575
-2.45%
 
VEXTF Vext Science, Inc.
0.1842
+5.08%
 
VV5.F Vext Science, Inc.
0.1610
+4.55%
 
FFNT.CN 4Front Ventures Corp.
0.1200
-4.00%
 
DBCCF Decibel Cannabis Company Inc.
0.0642
-3.17%